1.
2.
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
by Byrne, Christopher D
Diabetologia, 2016, Vol.59 (6), p.1141-1144
3.
Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease
by Abe, Masanori
Journal of gastroenterology, 2014, Vol.50 (7), p.776-784
4.
Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study
by Bano, Arjola
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (8), p.3204-3211
5.
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
by Watanabe, Sumio
Journal of gastroenterology, 2015, Vol.50 (4), p.364-377
6.
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
by Zarrinpar, Amir Amir
Gut, 2015, Vol.65 (9), p.1546-1554
7.
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
by Vuille-Lessard, Élise
AIDS (London), 2016, Vol.30 (17), p.2635-2643
8.
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study
by Isokuortti, Elina
Diabetologia, 2017, Vol.60 (10), p.1873-1882
9.
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
by Yoneda, Masato
Journal of gastroenterology, 2017, Vol.53 (2), p.181-196
10.
Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE
by Doycheva, I.
Alimentary pharmacology & therapeutics, 2016, Vol.43 (1), p.83-95
11.
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study
by Ishiba, Hiroshi
Journal of gastroenterology, 2018, Vol.53 (11), p.1216-1224
12.
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
by Tokushige, Katsutoshi
Journal of gastroenterology, 2021, Vol.56 (11), p.951-963
13.
Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression
by Segovia-Miranda, Fabián
Nature medicine, 2019, Vol.25 (12), p.1885-1893
14.
Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study
by Park, Hyo Eun
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (8), p.3134-3143
15.
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
by Munteanu, M.
Alimentary pharmacology & therapeutics, 2016, Vol.44 (8), p.877-889
16.
Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients With ST–Segment Elevation Myocardial Infarction
by Keskin, Muhammed
The American journal of cardiology, 2017, Vol.120 (10), p.1720-1726
17.
Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease
by Bosch, Dustin E
Human pathology, 2017, Vol.69, p.55-62
18.
The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic
by Roberts, K. K.
Alimentary pharmacology & therapeutics, 2015, Vol.41 (3), p.293-300
19.
Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease
by Liu, Feng
American journal of clinical pathology, 2017, Vol.148 (6), p.502-512
20.
Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans
by Gill, Clarence, MD
The American journal of cardiology, 2017, Vol.119 (11), p.1717-1722
